KalVista Pharmaceuticals, Inc.
KALV
$11.85
$0.100.85%
NASDAQ
| 07/31/2025 | 04/30/2025 | 01/31/2025 | 10/31/2024 | 07/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 191.47M | 220.62M | 253.20M | 135.78M | 174.27M |
| Total Receivables | 6.50M | 15.14M | 9.40M | 12.93M | 12.29M |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 7.93M | 5.93M | 4.75M | 3.56M | 5.07M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 205.90M | 241.69M | 267.36M | 152.27M | 191.63M |
|
|
|||||
| Total Current Assets | 205.90M | 241.69M | 267.36M | 152.27M | 191.63M |
| Net Property, Plant & Equipment | 7.23M | 7.53M | 7.25M | 7.90M | 7.96M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 2.38M | 1.55M | 1.39M | 662.00K | 605.00K |
| Total Assets | 215.51M | 250.77M | 275.99M | 160.83M | 200.20M |
|
|
|||||
| Total Accounts Payable | 5.87M | 4.88M | 5.86M | 5.20M | 10.79M |
| Total Accrued Expenses | 18.97M | 27.31M | 18.32M | 15.43M | 10.36M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 2.12M | 1.98M | 1.44M | 1.54M | 1.26M |
| Total Finance Division Other Current Liabilities | 11.41M | 11.00M | -- | -- | -- |
| Total Other Current Liabilities | 11.41M | 11.00M | -- | -- | -- |
| Total Current Liabilities | 38.38M | 45.17M | 25.62M | 22.16M | 22.41M |
|
|
|||||
| Total Current Liabilities | 38.38M | 45.17M | 25.62M | 22.16M | 22.41M |
| Long-Term Debt | 132.32M | 105.88M | 100.91M | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 4.02M | 4.33M | 4.34M | 4.68M | 4.99M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 174.72M | 155.38M | 130.87M | 26.84M | 27.40M |
|
|
|||||
| Common Stock & APIC | 760.44M | 753.78M | 748.28M | 689.13M | 685.84M |
| Retained Earnings | -713.27M | -653.17M | -600.95M | -552.44M | -510.17M |
| Treasury Stock & Other | -6.39M | -5.21M | -2.21M | -2.70M | -2.87M |
| Total Common Equity | 40.79M | 95.39M | 145.13M | 133.99M | 172.80M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 40.79M | 95.39M | 145.13M | 133.99M | 172.80M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 40.79M | 95.39M | 145.13M | 133.99M | 172.80M |
|
|
|||||